InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of “Hold” by Analysts

InMode Ltd. (NASDAQ:INMD) has been assigned an average recommendation of “Hold” from the eight ratings firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $16.00.

Several brokerages recently weighed in on INMD. Barclays set a $19.00 target price on shares of InMode and gave the company an “overweight” rating in a research note on Thursday, May 7th. Robert W. Baird lowered their price target on shares of InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a report on Thursday, May 7th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of InMode in a research report on Thursday, August 6th.

Institutional Trading of InMode

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Leonteq Securities AG purchased a new position in shares of InMode during the 4th quarter worth $26,000. Quadrant Capital Group LLC boosted its holdings in shares of InMode by 127.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock worth $29,000 after purchasing an additional 1,091 shares during the last quarter. Advisory Services Network LLC purchased a new stake in shares of InMode in the third quarter valued at $37,000. Basepoint Wealth LLC purchased a new stake in shares of InMode in the fourth quarter valued at $39,000. Finally, Deutsche Bank AG increased its stake in InMode by 35.9% in the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after purchasing an additional 1,037 shares during the last quarter. 68.04% of the stock is owned by hedge funds and other institutional investors.

InMode Stock Performance

InMode stock opened at $15.06 on Friday. The stock has a fifty day moving average of $14.83 and a two-hundred day moving average of $14.28. The company has a market capitalization of $865.65 million, a price-to-earnings ratio of 12.24 and a beta of 1.89. InMode has a fifty-two week low of $12.72 and a fifty-two week high of $16.74.

InMode (NASDAQ:INMD) last released its quarterly earnings results on Wednesday, August 5th. The healthcare company reported $0.35 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.35. The company had revenue of $95.59 million during the quarter, compared to analysts’ expectations of $94.89 million. InMode had a return on equity of 11.99% and a net margin of 20.69%.The business’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.47 earnings per share.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.